At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...

PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.

The therapy shrunk tumors in 46 percent of patients in a Phase I trial and showed strong PSA responses at the recommended dose.

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

KILIMANJARO: THE Moshi-based KCMC Zonal Referral Hospital (KCMC ZRH) has achieved a significant medical milestone after ...

Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...

Bhad Bhabie—who rose to fame on Dr. Phil in 2016—shared that she received “bad news” about her health amid her ongoing cancer battle.

Lord Brady discovered he had the disease after taking a PSA blood test that indicates cancer risk. This was followed by two ...

The peer said he had been living with the disease for two years but felt 'very lucky' to have benefited from the same ...